Generation of iPSCs from cultured human malignant cells.
about
Ebola virus entry requires the cholesterol transporter Niemann-Pick C1Drug Delivery Using Nanoparticles for Cancer Stem-Like Cell TargetingEchoes of the embryo: using the developmental biology toolkit to study cancerAn Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCsDifferentiation and transdifferentiation potentials of cancer stem cellsApplications of iPSCs in Cancer ResearchInduced pluripotent stem cell technology for dissecting the cancer epigenomeReprogramming of gastrointestinal cancer cellsAdvances and Challenges on Cancer Cells Reprogramming Using Induced Pluripotent Stem Cells TechnologiesIn vitro models of cancer stem cells and clinical applicationsModeling of Chronic Myeloid Leukemia: An Overview of In Vivo Murine and Human Xenograft ModelsConcise Review: Induced Pluripotent Stem Cells as New Model Systems in OncologyControl of Oxidative Stress and Generation of Induced Pluripotent Stem Cell-like Cells by Jun Dimerization Protein 2Human RGM249-derived small RNAs potentially regulate tumor malignancyInduced pluripotent mesenchymal stromal cell clones retain donor-derived differences in DNA methylation profiles.Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients.Susceptibility of Human Oral Squamous Cell Carcinoma (OSCC) H103 and H376 cell lines to Retroviral OSKM mediated reprogramming.Reprogramming of MLL-AF9 leukemia cells into pluripotent stem cells.Establishment of induced pluripotent stem cells from normal B cells and inducing AID expression in their differentiation into hematopoietic progenitor cells.Next-generation sequencing traces human induced pluripotent stem cell lines clonally generated from heterogeneous cancer tissue.iTRAQ-based quantitative proteomic analysis of Yamanaka factors reprogrammed breast cancer cells.Induced pluripotent stem cell: A headway in reprogramming with promising approach in regenerative biologyInduced Pluripotent Stem Cells-A New Foundation in MedicineApplication of epigenome-modifying small molecules in induced pluripotent stem cells.Heterogeneity of osteosarcoma cell lines led to variable responses in reprogrammingEfficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells.Human induced pluripotent stem cells can reach complete terminal maturation: in vivo and in vitro evidence in the erythropoietic differentiation model.Megabase-scale deletion using CRISPR/Cas9 to generate a fully haploid human cell line.Elite model for the generation of induced pluripotent cancer cells (iPCs).Variable behavior of iPSCs derived from CML patients for response to TKI and hematopoietic differentiation.A highly optimized protocol for reprogramming cancer cells to pluripotency using nonviral plasmid vectors.Myc transcription factors: key regulators behind establishment and maintenance of pluripotency.HIF induces human embryonic stem cell markers in cancer cells.Epigenetic reprogramming and re-differentiation of a Ewing sarcoma cell lineReprogramming of human cancer cells to pluripotency for models of cancer progressionThe crossroads between cancer stem cells and aging.Screening of drugs to treat 8p11 myeloproliferative syndrome using patient-derived induced pluripotent stem cells with fusion gene CEP110-FGFR1Dissecting the role of aberrant DNA methylation in human leukaemia.Induced pluripotent stem cell-related genes influence biological behavior and 5-fluorouracil sensitivity of colorectal cancer cells.Functional genomic screening approaches in mechanistic toxicology and potential future applications of CRISPR-Cas9.
P2860
Q24329246-A3ED153D-C271-4FA5-8990-5787D7865C55Q26752688-BD3EA7D5-73A7-4F45-A209-0560CBBEDAC5Q26770157-548642F3-903E-4926-939E-77D09C6A4F4DQ26775122-45BBE0D0-BF62-431B-B59F-93B6DF9EC62EQ26782242-8B19BB5E-2693-4134-AB42-F6F7B31A7F9AQ26798036-72DFAF06-35E5-426B-95DB-2CDAB85772E7Q26801711-76247909-691F-4480-9AE5-8CD8C12E2FAAQ26824284-A16B441D-7CED-43A3-B15D-FDCACCB503DEQ28071879-6E145993-7F3A-4619-9539-93E65D7D89B3Q28076101-1808D612-EA01-4D51-8FB8-21E4974921E5Q28076328-C922D67B-775A-4C19-9F80-0AA0DC3E5DF8Q28080945-FF8734FE-0945-4CCB-B82F-E09F24570D13Q28301456-D0D7A39A-DC43-4729-AA69-3DDACF74FDA1Q28681257-AF3C4D85-DAB1-4099-91E4-C4086CA0E658Q30531604-FEC96C60-B728-4CB9-8E1B-265A571F7F6FQ33414617-D4C06236-09D2-4489-AC86-9A018EA29869Q33566486-5824D009-2834-4879-947E-78A1DDE68FD0Q33595654-19754687-86DF-4D1F-AEC2-2654A86BF4C2Q33687796-5AC45297-428A-4F40-AC92-2FFF29DC444EQ33716184-184938BD-0895-4827-9ED1-9A6B1033A87DQ33798347-DC44E4A4-F66C-4FD2-B9F9-284ED2C9B4F1Q33877155-51C99D19-C305-45E4-B602-D2128D8C1F4BQ34031081-68662DDF-7CA5-4206-B203-F6554852F3EBQ34031951-55BAF234-031A-4ADE-B26A-EE6D91C3D0FBQ34102068-EE46997C-6BC4-400C-A538-ED2E1B68B28FQ34162877-0517BE66-5FC8-406E-9915-DE521A89A1A8Q34284032-AEBA6FD9-043B-421D-A8DB-ECD226526B38Q34446440-6E45CC19-7E24-418C-8F87-289B2A2C4E70Q34590216-AF98D3D3-CB07-40C3-A90B-1D16AAC17C7EQ34994180-79FA18D8-E69E-4B9D-B8AC-5E881E481D87Q35034687-3FA6A666-173E-434E-A788-30BEF9C04A8AQ35054858-B4EC9341-CC76-42C7-A43D-7110EB03B3BBQ35085958-F7F4CDFD-39AD-4EA9-AF63-61E6C82346BCQ35158389-103330B9-F199-4768-B6DE-529EA36D5AC8Q35204997-7ADED4B4-11F8-43B0-A82B-D34F914BBBF5Q35566484-5E1E5C52-C5F5-4ADC-9F4C-2E1BC436B75FQ35585501-A751131A-C100-4FE3-BB23-1E3FE0E7E41EQ35645500-DE3EC281-2A8A-4A4A-B570-5F93C5BEAB7EQ35653328-9873A8DD-9D68-42DD-BA42-4626218AECE5Q35686057-9C3675EA-E129-4046-A412-620CD00E69DF
P2860
Generation of iPSCs from cultured human malignant cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Generation of iPSCs from cultured human malignant cells.
@ast
Generation of iPSCs from cultured human malignant cells.
@en
type
label
Generation of iPSCs from cultured human malignant cells.
@ast
Generation of iPSCs from cultured human malignant cells.
@en
prefLabel
Generation of iPSCs from cultured human malignant cells.
@ast
Generation of iPSCs from cultured human malignant cells.
@en
P2093
P2860
P50
P1433
P1476
Generation of iPSCs from cultured human malignant cells.
@en
P2093
Fernando D Camargo
Malini Varadarajan
Sumita Gokhale
Thijn R Brummelkamp
Vincent A Blomen
P2860
P304
P356
10.1182/BLOOD-2009-07-231845
P407
P577
2010-03-16T00:00:00Z